Ginkgo Bioworks Holdings (DNA) Other financing activities (2020 - 2024)

Ginkgo Bioworks Holdings (DNA) has reported Other financing activities for 5 consecutive years, with $14000.0 the latest figure, recorded in Q2 2024.

• For the quarter ending Q2 2024, Other financing activities rose 102.28% year-over-year to $14000.0; the trailing twelve-month figure through Mar 2025 stood at $14000.0 (down 97.81% YoY), and the FY2024 full-year result was $84000.0, down 85.52% from the prior year.
• Other financing activities retreated to $14000.0 in Q2 2024 per DNA's latest filing, from $70000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $100.3 million in Q4 2022 and bottomed at -$980000.0 in Q2 2022.
• Historically, Other financing activities has averaged $10.7 million across 5 years, with a median of $12000.0 in 2021.
• The sharpest annual moves came in 2021 and 2022: Other financing activities surged 855500.0% in 2021, then slumped 8266.67% in 2022.
• Over 5 years, Other financing activities stood at $7000.0 in 2020, then soared by 855500.0% to $59.9 million in 2021, then soared by 67.46% to $100.3 million in 2022, then plunged by 98.82% to $1.2 million in 2023, then tumbled by 98.82% to $14000.0 in 2024.
• According to Business Quant data, Other financing activities over the past three periods registered $14000.0, $70000.0, and $1.2 million for Q2 2024, Q1 2024, and Q4 2023 respectively.